A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine

Amaal Starling, Bert B. Vargas

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.

Original languageEnglish (US)
Article number49
JournalCurrent Pain and Headache Reports
Volume19
Issue number10
DOIs
StatePublished - Oct 21 2015

Fingerprint

Migraine Disorders
Therapeutics
Patient Education
Economics
Injections
Research
Population

Keywords

  • Chronic daily headache
  • Chronic migraine
  • Headache
  • Migraine
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine. / Starling, Amaal; Vargas, Bert B.

In: Current Pain and Headache Reports, Vol. 19, No. 10, 49, 21.10.2015.

Research output: Contribution to journalArticle

@article{b509a2c2efd34e3597fc82f2031d15ef,
title = "A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine",
abstract = "Chronic migraine is a debilitating disorder that affects 2 {\%} of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.",
keywords = "Chronic daily headache, Chronic migraine, Headache, Migraine, Treatment",
author = "Amaal Starling and Vargas, {Bert B.}",
year = "2015",
month = "10",
day = "21",
doi = "10.1007/s11916-015-0521-0",
language = "English (US)",
volume = "19",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Current Science, Inc.",
number = "10",

}

TY - JOUR

T1 - A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine

AU - Starling, Amaal

AU - Vargas, Bert B.

PY - 2015/10/21

Y1 - 2015/10/21

N2 - Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.

AB - Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.

KW - Chronic daily headache

KW - Chronic migraine

KW - Headache

KW - Migraine

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84939621293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939621293&partnerID=8YFLogxK

U2 - 10.1007/s11916-015-0521-0

DO - 10.1007/s11916-015-0521-0

M3 - Article

C2 - 26286071

AN - SCOPUS:84939621293

VL - 19

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 10

M1 - 49

ER -